Clinical Trial Update: Atrial Fibrillation Ablation The Hybrid Approach Versus Traditional Management [EARLY_Phase 1]

View source ↗

Summary

A clinical trial evaluating a hybrid atrial fibrillation ablation approach versus traditional management has been withdrawn from the EARLY Phase 1 study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Inova Health Care Services | Conditions: Ablation of Atrial Fibrillation | EARLY_Phase 1 | Status: WITHDRAWN